SCHEMBL29544852

SCHEMBL29544852

COc1c(F)cccc1Nc1c(-c2ccncc2F)nn2c1C(=O)NCC2

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EGFR P00533 17/20 0.49
ROCK2 O75116 2/20 0.36
BUB1 O43683 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29544860 1.00 EGFR (0.49) EGFRROCK2BUB1
SCHEMBL29544730 0.92 EGFR (0.42) EGFRBUB1
SCHEMBL29545225 0.92 EGFR (0.47) EGFRROCK2
SCHEMBL29544775 0.92 EGFR (0.47) EGFRROCK2
SCHEMBL29544795 0.89 EGFR (0.48) EGFRROCK2
SCHEMBL29544784 0.88 EGFR (0.51) EGFR
SCHEMBL29544404 0.87 EGFR (0.43) EGFR
SCHEMBL29545545 0.87 EGFR (0.45) EGFR
SCHEMBL29545007 0.87 EGFR (0.47) EGFR
SCHEMBL29544687 0.87 EGFR (0.43) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022072634-A1 BICYCLIC COMPOUNDS FOR USE IN THE TREATMENT CANCER SCORPION THERAPEUTICS, INC. (US) 2022-04-07 WO disclosed